Literature DB >> 12749606

Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults.

Masahiko Ando1, Nobuyuki Hamajima, Noritaka Ariyoshi, Tetsuya Kamataki, Keitaro Matsuo, Yoshiyuki Ohno.   

Abstract

BACKGROUND: Genetic variation of CYP2A6 is shown to alter nicotine metabolism. This study was developed to investigate the genetic influence of the whole deletion-allele of CYP2A6 on active and passive smoking behavior.
METHODS: Two hundred and forty Japanese adults, who visited Aichi Cancer Center as outpatients, were genotyped for the wild-type (CYP2A6*1A, CYP2A6*1B) and the whole deletion-type (CYP2A6*4C) polymorphism of CYP2A6. Information about active and passive smoking status was obtained by a self-administered questionnaire. Genetic influence of CYP2A6 polymorphism on smoking behavior was evaluated using the Mantel extension test.
RESULTS: The frequency of the deletion allele was 18%. All 8 subjects carrying two deletion alleles had no smoking habit, and the homozygous deletion genotype showed a tendency to correlate with active smoking status after adjustment for sex and age (p = 0.054). However, the proportion of never smokers among heterozygous subjects was almost the same as among subjects carrying no deletion allele (54% and 58%, respectively). Furthermore, CYP2A6 genotypes were correlated neither with the number of cigarettes smoked per day nor with the age at starting smoking (p = 0.364 and 0.880, respectively). Among never smokers, CYP2A6 genotypes were not correlated with exposure to passive smoking at home or in the workplace (p = 0.623 and 0.484, respectively).
CONCLUSION: Despite the possible protection against active smoking behavior in subjects homozygous for the deletion allele, the CYP2A6 polymorphism has only a limited impact on public health because no protective effect was found in heterozygous subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749606     DOI: 10.2188/jea.13.176

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  11 in total

1.  Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.

Authors:  J O'Loughlin; G Paradis; W Kim; J DiFranza; G Meshefedjian; E McMillan-Davey; S Wong; J Hanley; R F Tyndale
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

2.  A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.

Authors:  Man Ki Ho; Jill C Mwenifumbo; Bin Zhao; Elizabeth M J Gillam; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2008-01       Impact factor: 2.089

Review 3.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Authors:  Navneet Momi; Sukhwinder Kaur; Moorthy P Ponnusamy; Sushil Kumar; Uwe A Wittel; Surinder K Batra
Journal:  Carcinogenesis       Date:  2012-05-23       Impact factor: 4.944

4.  EFFECT OF CYP2A6*4 GENETIC POLYMORPHISMS ON SMOKING BEHAVIORS AND NICOTINE DEPENDENCE IN A GENERAL POPULATION OF JAPANESE MEN.

Authors:  Teruna Ito; Masayoshi Tsuji; Yayoi Mori; Hideyuki Kanda; Tomoo Hidaka; Takeyasu Kakamu; Tomohiro Kumagai; Takehito Hayakawa; Yoneatsu Osaki; And Tetsuhito Fukushima
Journal:  Fukushima J Med Sci       Date:  2015-09-11

Review 5.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

Review 6.  The genetics of nicotine dependence: relationship to pancreatic cancer.

Authors:  Stewart L MacLeod; Parimal Chowdhury
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

7.  Phenotypic CYP2A6 variation and the risk of pancreatic cancer.

Authors:  Susan Kadlubar; Jeffrey P Anderson; Carol Sweeney; Myron D Gross; Nicholas P Lang; Fred F Kadlubar; Kristin E Anderson
Journal:  JOP       Date:  2009-05-18

8.  Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 Inhibition.

Authors:  Travis T Denton; Pramod Srivastava; Zuping Xia; Gang Chen; Christy J W Watson; Alec Wynd; Philip Lazarus
Journal:  J Med Chem       Date:  2018-08-01       Impact factor: 7.446

9.  Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.

Authors:  Lisa Sanderson Cox; Babalola Faseru; Matthew S Mayo; Ron Krebill; Tricia S Snow; Carrie A Bronars; Nicole L Nollen; Won S Choi; Kolawole S Okuyemi; Gary A Salzman; Neal L Benowitz; Rachel F Tyndale; Jasjit S Ahluwalia
Journal:  Trials       Date:  2011-01-25       Impact factor: 2.279

10.  Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.

Authors:  Masanori Ohmoto; Tatsuo Takahashi; Yoko Kubota; Shinjiro Kobayashi; Yasuhide Mitsumoto
Journal:  BMC Genet       Date:  2014-12-20       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.